IONS
NASDAQStockIonis Pharmaceuticals, Inc.
$72.52-2.31 (-3.09%)
52-Week Range
$25.51
$86.50
Key Stats
Market Cap
12.0B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.36
Volume
1.3M
Avg Volume
2.6M
Performance
1M
-14.24%
3M
-9.30%
6M
+18.40%
YTD
-9.20%
1Y
+119.88%
3Y
+114.28%
5Y
+32.44%
Price Chart
ETF Exposure
IONS is held by 145 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MEDX | Horizon Kinetics Medical ETF | 4.66% |
| MSGR | Direxion mRNA ETF | 4.10% |
| MNTL | Tema Neuroscience And Mental Health ETF | 3.48% |
| PBE | Invesco Biotechnology & Genome ETF | 2.54% |
| FXH | First Trust Health Care AlphaDEX Fund | 2.19% |
| HELX | Franklin Genomic Advancements ETF | 2.08% |
| WDNA | WisdomTree BioRevolution Fund | 1.99% |
| BBP | Virtus Biotech ETF | 1.43% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 1.36% |
| CGMM | Capital Group U.S. Small and Mid Cap ETF | 1.34% |
| MRND | IQ U.S. Mid Cap R&D Leaders ETF | 1.32% |
| XBI | State Street SPDR S&P Biotech ETF | 1.18% |
| IBB | iShares Biotechnology ETF | 1.05% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.93% |
| SMOT | VanEck Morningstar SMID Moat ETF | 0.88% |
| JDOC | JPMorgan Healthcare Leaders ETF | 0.83% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 0.81% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.71% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.69% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.63% |
| CVRT | Calamos Convertible Equity Alternative ETF | 0.63% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 0.62% |
| FDMO | FIDELITY MOMENTUM FACTOR ETF | 0.60% |
| MEDI | Harbor Health Care ETF (MEDI) | 0.57% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.57% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.50% |
| SMMV | iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.46% |
| VBK | Vanguard Small-Cap Growth ETF | 0.41% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.40% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.40% |
| CGGR | Capital Group Growth ETF | 0.40% |
| IWP | iShares Russell Mid-Cap Growth ETF | 0.38% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.35% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.35% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.34% |
| FLDZ | RiverNorth Patriot ETF | 0.34% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.32% |
| STXM | Strive Mid-Cap ETF | 0.31% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.30% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.30% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.29% |
| NXTI | Simplify NEXT Intangible Core Index ETF | 0.27% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.27% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.27% |
| SCHM | Schwab U.S. Mid-Cap ETF | 0.25% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.25% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 0.24% |
| FFLG | FIDELITY FUNDAMENTAL LARGE CAP GROWTH ETF | 0.24% |
| PWS | Pacer WealthShield ETF | 0.24% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.23% |
Page 1 of 3Next
About IONS ETF Exposure
Ionis Pharmaceuticals, Inc. (IONS) is held by 145 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 12.0B, IONS is a widely held institutional stock. The stock currently trades at $72.52. Investors can gain exposure to IONS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IONS, sorted by portfolio weight.